Thalidomide's Legacy

The FDA played a crucial role in preventing thalidomide from entering the American market, potentially saving countless children from birth defects. This incident highlighted the importance of testing all possible stereoisomers of drugs, leading to new regulations that emphasized enantiopurity in drug development. The lessons learned from this tragedy continue to shape safety protocols in the pharmaceutical industry today.